MYT yields 92.59% · JNJ yields 2.13%● Live data
📍 MYT pulled ahead of the other in Year 1
Combined, MYT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYT + JNJ for your $10,000?
Urban Tea, Inc. engages in the supply and distribution of tea beverages and related products. The company is headquartered in Zhenjiang, Jiangsu and currently employs 65 full-time employees. The firm is a chemical manufacturer, which is engaged in manufacturing and selling of organic compounds, including para-chlorotoluene (PCT), ortho-chlorotoluene (OCT), PCT/OCT downstream products, unsaturated polyester resin (UPR), maleic acid (MA) and other by-product chemicals, and distributing fine and specialty chemicals to end application markets, including automotive, pharmaceutical, agrochemical, dye and pigments, aerospace, ceramics, coating-printing, clean energy and food additives. The firm's products are PCT/OCT and UPR. The PCT/OCT products together with its downstream products can be used in pharmaceuticals, pesticides, dyes and consumables manufacturing industries. UPR is used as renovation material for bathroom and kitchen; manufacturing materials for trains, cars, aircrafts and vessels, and infrastructure materials, such as anti-collusion pipes and oil and gas pipelines.
Full MYT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.